Delivery Order SPE2DR25D3103-SPE2DR26F0D2E
Award Date 2/18/26
Potential Completion Date 2/19/26
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,746.48 to AmerisourceBergen Drug Corp for the supply of Emtricitabine-Tenofovir 200-300mg tablets in a 30-day supply package. This non-competitive delivery order, issued on October 30, 2025, represents a firm fixed-price procurement of pharmaceutical products with an ultimate completion date of October 31, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $14,424.27 delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg units in quantities of 30. The contract represents a firm fixed-price delivery order with an ultimate completion date of July 18, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg tablets in units of 30 with a ceiling value of $2,162.91. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a non-competitive award issued under an existing contract vehicle and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Emtricitabine-Tenofovir (200-300mg) in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $3,198.40 and an ultimate completion date of August 22, 2025. The contract was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $2,060.00 delivery order to AmerisourceBergen Drug Corp for a 30-day supply of Emtricitabine-Tenofovir 200-300mg on October 30, 2025, with an ultimate completion date of October 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,897.59 to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by November 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg tablets in quantities of 30 units, with a ceiling value of $2,235.38. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, representing a single-unit pharmaceutical procurement without set-aside designation. The award was made competitively to AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $1,111.68, for the supply of Emtricitabine-Tenofovir 200-300mg unit dose packaging in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of September 23, 2025, and was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,785.13 with firm fixed pricing and an ultimate completion date of September 9, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this...
- The U.S. Defense Department's Medical Supply Chain awarded a firm fixed-price delivery order valued at $3,620.08 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Emtricitabine-Tenofovir 200-300 mg tablets in quantities of 30. This non-competitive delivery order, which serves military and federal healthcare systems, represents a single transaction under AmerisourceBergen's larger contract vehicle with the Defense Logistics Agency. The pharmaceutical products will be...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F0D2EDelivery Order
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 18, 2026, with a ceiling value of $1,073.29 for emficitabine-tenofovir 200–300 mg in 30-count units. Place of performance is Conshohocken, PA. The order carries an ultimate completion date of February 19, 2026, and is priced firm fixed price with no set-aside applied. This delivery order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and running through December 2026, which supports military healthcare programs globally with a range of pharmaceutical products and medical supplies.
Generated 5/20/26, 9:53 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 2/17/26 |